ME
McIlrath & Eck’s Athira Pharma ATHA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $249 | Hold |
825
| – | – | ﹤0.01% | 912 |
|
2025
Q1 | $235 | Hold |
825
| – | – | ﹤0.01% | 906 |
|
2024
Q4 | $484 | Hold |
825
| – | – | ﹤0.01% | 938 |
|
2024
Q3 | $368 | Hold |
825
| – | – | ﹤0.01% | 941 |
|
2024
Q2 | $2.19K | Hold |
825
| – | – | ﹤0.01% | 818 |
|
2024
Q1 | $2.26K | Hold |
825
| – | – | ﹤0.01% | 812 |
|
2023
Q4 | $2.01K | Hold |
825
| – | – | ﹤0.01% | 804 |
|
2023
Q3 | $1.67K | Hold |
825
| – | – | ﹤0.01% | 784 |
|
2023
Q2 | $2.43K | Hold |
825
| – | – | ﹤0.01% | 769 |
|
2023
Q1 | $2.06K | Hold |
825
| – | – | ﹤0.01% | 774 |
|
2022
Q4 | $2.62K | Hold |
825
| – | – | ﹤0.01% | 726 |
|
2022
Q3 | $2K | Hold |
825
| – | – | ﹤0.01% | 741 |
|
2022
Q2 | $3K | Hold |
825
| – | – | ﹤0.01% | 676 |
|
2022
Q1 | $11K | Hold |
825
| – | – | ﹤0.01% | 506 |
|
2021
Q4 | $11K | Buy |
+825
| New | +$11K | ﹤0.01% | 518 |
|